Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

NCT06658379 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT06658379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06658379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2016
Completion date
June 30, 2025
Enrollment
640 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

distal tibia fracture, femoral neck fractures, femoral shaft fracture, femur distal fracture, forearm fracture, fracture healing, fracture non union, humerus shaft fracture, long bone delayed-union fracture, pertrochanteric fracture of femur, proximal tibia fracture, tibial shaft fracture